Companies/GlucoTrack, Inc.

Company profile

GlucoTrack, Inc.

NASDAQ: GCTK · Healthcare · Medical - Instruments & Supplies

PublicHQ Rutherford, CIK 0001506983Reports USD

#993 of 1,402 Healthcare companies by revenuetop-decile growth

EA Score

26D

FH 17DQ —GM 45SS 39

v0.1 · 45/100 weight · provisional

↑ revenue growth (YoY), listing tenure · ↓ return on equity, net margin

Methodology →

Revenue TTM

$208.8k

Rev growth YoY (TTM)

needs 8 qtrs

Net income (FY)

-$19.4M

Employees

Market cap

$263.1k

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Revenue$208.8k$208.8k2019

Net income-$19.4M-$19.4M2025

Operating income-$16.1M-$16.1M2025

Total assets$7.8M$7.8M2025

Liabilities$5.0M$5.0M2025

Equity$2.8M$2.8M2025

Revenue trend

FY2014 – FY2019 · USD

$59.8k

FY14

$143.2k

FY15

$611.7k

FY16

$589.5k

FY18

$43.5k

FY18

$208.8k

FY19

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

GlucoTrack, Inc. booked $208.8k in FY2019 revenue, growing 380% year over year — faster than 93% of Healthcare companies we track, at a -9287.1% net margin.

Peers · Healthcare

FutureWorld Corp.——Multicorp International, Inc.——Marijuana Inc.——Aoxing Pharmaceutical Company, Inc.——

Key facts

CEOPaul V. Goode

SectorHealthcare

IndustryMedical - Instruments & Supplies

HeadquartersRutherford, null

ExchangeNASDAQ: GCTK

Employees15

IPO date2013-04-25

Latest filings

No filings loaded.

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.